A new discovery could change how type 1 diabetes is diagnosed and managed in individuals of African descent, researchers say.

Diabetes mellitus is most commonly known as diabetes, ... Type 1 is an autoimmune disease and is when the immune system attacks the cells that produce insulin.

Discover a study uncovering how JAK inhibitors protect against autoimmune diabetes triggered by cancer immunotherapy.

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop diabetes after immunotherapy.

Type I Diabetes Mellitus (T1D) is an autoimmune disorder leading to permanent loss of insulin-producing beta-cells in the pancreas. In a new study, researchers from The University of Tokyo ...

Both animal and human studies have demonstrated that anti-CD3 antibodies, like otelixizumab, are able to reverse autoimmune diseases for example Type 1 diabetes. Not only does treatment with anti ...

People who are not overweight with diabetes can have several different problems, including Type 1 diabetes (an autoimmune disease where the insulin-producing cells are attacked); antibodies to the ...

(2021) A Patient with Atezolizumab-Induced Autoimmune Diabetes Mellitus Presenting with Diabetic Ketoacidosis. Cardiovascular Innovations and Applications. doi. org/ 10. 15212/ CVIA. 2021. 0007 .